Anticancer Research is an international journal designed to rapidly publish original papers and reviews on experimental and clinical cancer research. Anticancer Research was established in 1981 by J.G. Delinasios. In this site you may find information concerning the editorial board, editorial policy, subscriptions, submission of manuscripts, online open articles, advertising, special offers for authors and a current list of accepted manuscripts.
Ovarian Cancer Immunology and Immunotherapy– 2026
1. TOPICS:
● T Cells and Tumor-Infiltrating Lymphocytes (TILs):
o CD8⁺ cytotoxic T cells
o CD4⁺ T cells
o Progenitor stem-like memory T cells
o Clonally expanded T cells and T-cell receptors
● Antigen-Presentation and HLA associations:
o Antigen-presenting cells (dendritic cells and others)
o HLA associations
● Tumor Antigens:
o Tumor-associated antigens
o Tumor-specific antigens. Neoantigens. TP53, RAS
● Tumor Genetics and Variants:
o Genetic and somatic variations of tumor cells
● B cells and Autoantibodies. Cytokines.
● Natural Killer (NK) Cells and Innate Immunity.
● Tumor Microenvironment.
● Immunosuppression:
o Immunosuppressive cells: Tregs, myeloid-derived suppressor cells, tumor-associated macrophages
o Immunosuppressive molecules (IL-10, TGF-β, others)
● Single-cell analysis studies.
● Checkpoint Inhibitors and Immune Modulation:
o PD-1, PD-L1, and other checkpoints
● Immunotherapy Approaches:
o Adoptive cell therapies (TILs, CARs)
o Immune response modulators
o Animal models of ovarian cancer
2. Deadline for article(s) submission: February 5, 2026.
3. The special issue is scheduled for publication in April 2026.
4. Manuscripts (reviews and original experimental or clinical research articles) should follow the Instructions for Authors of Anticancer Research and should be submitted for publication through our new online submission system: www.iiar-
The Special Issue of Anticancer Research on NEW ANTICANCER AGENTS 2025 is now published
and can be found here.
Articles in ANTICANCER RESEARCH are fully available to everyone as open access 2 years after publication.
Library Recommendation Form
Please print and complete this form. Send or give the completed form to your librarian to recommend Anticancer Research.
Thank you.
Contents of Current Issue
Archive of All Online Issues (January 2004 – Present)
 |
Your link to essential information on cancer research published in the last 44 years.
|
ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
e-mail: journals@iiar-anticancer.org
Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389
e-mail:journals@iiar-anticancer.org